Iman Akbarzadeh at School of Life Sciences, Faculty of Science, University of Technology Sydney, NSW, Australia.
Mr. Iman Akbarzadeh is an emerging researcher in the field of biomedical science, currently pursuing his Ph.D. at the University of Technology Sydney. His academic background in chemical engineering and biotechnology underpins his multidisciplinary approach to tackling major biomedical challenges. Mr. Akbarzadeh has contributed significantly to cutting-edge research in nanotechnology-based drug delivery, with a strong emphasis on preeclampsia treatment and cancer therapy. He has held research positions at several prestigious institutions in Iran, including the Research Institute for Gastroenterology & Liver Diseases, the Pasteur Institute, and Sharif University of Technology. His work has culminated in multiple high-impact publications in journals such as Coordination Chemistry Reviews and Biomaterials Advances. Beyond publishing, he actively contributes to the scientific community as a peer reviewer for top-tier journals including Pharmaceutics and the International Journal of Biological Macromolecules. With a robust skill set ranging from nanoparticle synthesis to advanced analytical techniques and a growing list of academic accolades, Mr. Akbarzadeh is poised to make impactful contributions to translational medicine and nanotherapeutics.
Publication Profile
Scopus
Educational Details
- 2024 – Present: Ph.D. in Biomedical Science, University of Technology Sydney, Australia
Thesis Topic: Developing Novel Strategies to Monitor and Treat Preeclampsia Using Nanotechnology Approaches.
- 2016 – 2019: M.Sc. in Chemical Engineering – Biotechnology, Sharif University of Technology, Iran
Thesis Topic: Niosomal Delivery of Simvastatin to MDA-MB-231 Cancer Cells.
- 2012 – 2016: B.Sc. in Chemical Engineering, Ferdowsi University of Mashhad, Iran
Professional Experience
- 2020 – 2024: Researcher, Research Institute for Gastroenterology & Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
- 2017 – 2023: Researcher, Nanobiotechnology Department, Pasteur Institute, Tehran, Iran
- 2019 – 2023: Researcher, Nanotechnology and Drug Delivery Laboratory, Sharif University of Technology, Tehran, Iran
Mr. Akbarzadeh has played a vital role in executing projects related to drug delivery, antimicrobial therapies, and nanoparticle engineering. These positions allowed him to gain practical experience in multidisciplinary research teams focused on translational outcomes.
Research Interest
Mr. Akbarzadeh’s research interests include:
- Drug and Gene Delivery
- Preeclampsia and Pregnancy-related Complications
- Cancer Research and Targeted Therapy
- Tissue Engineering and Regenerative Medicine
- 3D Bioprinting for Biomedical Applications
- Wound Healing and Biomaterials
- Microfluidics for Drug Screening
- Extracellular Vesicles (EVs) and Intercellular Communication
Research Skills
Mr. Akbarzadeh possesses a wide range of technical and analytical skills, including:
- Cell Culture and Assays: Cell culture, MTT assay, flow cytometry
- Microbiology: Biofilm test, MIC-MBS assay, disk diffusion, time-kill assay
- Biochemistry: BCA assay, ELISA
- Analytical Methods: HPLC, UV-Vis, DLS, TEM, SEM, FTIR, XRD, DSC
- Nanoparticle Synthesis: Lipid, metal, mesoporous silica, and polymeric nanoparticles
- Software Proficiency: Microsoft Office, GraphPad, FIJI, SPSS, Design-Expert, Photoshop, MATLAB, BioRender, OriginPro
Awards and Honors
- Recipient of the International Research Award on New Science Inventions in the “Best Research Award” category, 2021
- Ranked 17th out of ~10,000 in Iran’s nationwide Master’s entrance exam, 2017
- Ranked in the top 3% out of ~300,000 in Iran’s nationwide Bachelor’s entrance exam, 2012
These distinctions highlight Mr. Akbarzadeh’s academic excellence and his recognition as a leading talent in his field.
Author Metrics
-
Total Publications: 54
-
Total Citations: 2,171
-
h-index: 21
-
i10-index: 35
Top Noted Publication
-
Azari Torbat, N., Akbarzadeh, I., Rezaei, N., Moghaddam, Z., Bazzazan, S., Mostafavi, E.
“Curcumin-Incorporated Biomaterials: In silico and in vitro evaluation of biological potentials.”
Coordination Chemistry Reviews, 2023.
Impact Factor (IF): 20.3
Note: I. Akbarzadeh and N. Azari Torbat contributed equally to this work.
-
Akbarzadeh, I., Rezaei, N., Bazzazan, S., Naderi Mezajin, M., Mansouri, A., Karbalaeiheidar, H., Ashkezari, S., Salehi Moghaddam, Z., Asghari Lalami, Z., Mostafavi, E.
“In Silico and In Vitro Studies of GENT-EDTA Encapsulated Niosomes: A Novel Approach to Enhance the Antibacterial Activity and Biofilm Inhibition in Drug-Resistant Klebsiella pneumoniae.”
Biomaterials Advances, 2023.
Impact Factor (IF): 5.5
-
Dastneshan, A., Rahiminezhad, S., Naderi Mezajin, M., Nouri, H., Akbarzadeh, I., Jahanbakhshi, M., Abdihaji, M., Qahremani, R., Asghari Lalami, Z., Heydari, H., Noorbazargan, H., Mostafavi, E.
“In Vitro, and In Vivo, Studies of Cefazolin Encapsulated UiO-66-NH₂: A New Approach for Enhanced Antibacterial Activity and Biofilm Inhibition in Drug-Resistant Staphylococcus aureus.”
Chemical Engineering Journal, 2023.
Impact Factor (IF): 13.4
-
Mansoori-Kermani, A., Khalighi, S., Akbarzadeh, I., Jahed, V., Motasadizadeh, H., Ranjbar Niavol, F., Mahdieh, A., Abdinezhad, M., Rahbariasr, N., Hosseini, M., Ahmadkhani, N., Panahi, B., Fatahi, Y., Batiha, G.E.S., Mozafari, M., Mostafavi, E.
“Engineered Hyaluronic Acid-Decorated Niosomal Nanoparticles for Controlled and Targeted Delivery of Epirubicin to Treat Breast Cancer.”
Materials Today Bio, 2022.
Impact Factor (IF): 8.7
-
Akbarzadeh, I., Saremi Poor, A., Khodarahmi, M., Abdihaji, M., Moammeri, A., Jafari, S., Salehi Moghaddam, Z., Seif, M., Moghtaderi, M., Asghari Lalami, Z., Heydari, M., Adelnia, H., Farasati Far, B.
“Gingerol/Letrozole-Loaded Mesoporous Silica Nanoparticles for Breast Cancer Therapy: In-Silico and In-Vitro Studies.”
Microporous and Mesoporous Materials, 2022.
Impact Factor (IF): 4.8
-
Ghafelehbashi, R., Akbarzadeh, I., Tavakkoli Yaraki, M., Lajevardi, A., Fatemizadeh, M., Heidarpoor Saremi, L.
“Preparation, Physicochemical Properties, In Vitro Evaluation and Release Behavior of Cephalexin-Loaded Niosomes.”
International Journal of Pharmaceutics, 2019.
Impact Factor (IF): 5.3
Conclusion
Mr. Iman Akbarzadeh is a dedicated and accomplished biomedical researcher with a unique interdisciplinary foundation in chemical engineering and nanobiotechnology. He is currently expanding the frontiers of knowledge in maternal-fetal health through his doctoral research in preeclampsia. With experience in leading research institutes, a portfolio of high-impact publications, and an active role in scientific peer review, Mr. Akbarzadeh demonstrates strong potential for future leadership in biomedical innovation. His technical competencies and scholarly contributions are instrumental to advancing novel diagnostic and therapeutic strategies in medicine.